Named on 3 rounds in the feed, most often at Series B.
Rounds from 2025-12-09 to 2026-09-01
ROUNDS
3
led 1, joined 2
LED ROUNDS · USD
$447.0M
across 1 round
CO-INVESTORS
29
named beside it
Named on 3 rounds in the feed, most often at Series B.
Rounds from 2025-12-09 to 2026-09-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Tripo AI A generative 3D foundation models company | Series B Verified against 4 of 7 sources | $447.0M | 2026-09-01 | [ LEAD ] |
Aureka Biotechnologies Aureka Biotechnologies develops AI-driven therapeutic discovery technologies to create high-value protein therapeutics for disease treatment. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-08-10 | [ PART ] |
D3 Bio D3 Bio develops innovative and efficacious medicines focused on oncology and immunology, targeting unmet patient needs. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $108M | 2025-12-09 | [ PART ] |